Syntropic

Syntropic develops novel new treatments for psychiatric disorders.

Syntropic is a pre‑clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition.

Mark  Caffrey

Mark Caffrey

  • Co-Founder and CEO
Alessandro Venturino

Alessandro Venturino

  • Co-Founder and Head of Research
Jack  O'Keeffe

Jack O'Keeffe

  • Co-Founder and CTO
Sandra  Siegert

Sandra Siegert

  • Co-Founder and Scientific Advisor